Literature DB >> 8590041

Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia.

D E Palm1, N W Knuckey, M J Primiano, A G Spangenberger, C E Johanson.   

Abstract

Cystatin C, a cysteine protease inhibitor produced by the choroid plexus and found in CSF at high concentrations, may have an important role in brain injury. We used the two-vessel occlusion model with hypotension to induce transient forebrain ischemia (TFI) in rats for 10 min and then examined cystatin C immuno-like reactivity (CC-IR) after 1, 3, 7 and 14 days of recovery. Our results reveal that CC-IR was minimal or absent in the hippocampus of normal and 1 day post-ischemic animals. However, CC-IR was present in CA1 pyramidal cells and a small number of reactive glia of the stratum radiatum (SR) and stratum oriens (SO) at 3, 7 and 14 days post-ischemia. Histological assessment of the hippocampus indicates that CC-IR was localized in morphologically degenerative neurons. This distinct temporal expression of cystatin C in the rat hippocampus is concurrent with delayed neuronal death following TFI. Thus, these results indicate that cystatin C and/or its substrates may be important components of the post-ischemic neurodegenerative and repair process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590041     DOI: 10.1016/0006-8993(95)00520-z

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

Review 1.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

2.  Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurotox Res       Date:  2019-07-02       Impact factor: 3.911

3.  Stabilized Human Cystatin C Variant L47C/G69C Is a Better Reporter Than the Wild-Type Inhibitor for Characterizing the Thermodynamics of Binding to Cysteine Proteases.

Authors:  David O Tovar-Anaya; L Irais Vera-Robles; M Teresa Vieyra-Eusebio; Ponciano García-Gutiérrez; Francisco Reyes-Espinosa; Andrés Hernández-Arana; J Alfonso Arroyo-Reyna; Rafael A Zubillaga
Journal:  Protein J       Date:  2019-10       Impact factor: 2.371

4.  Elevation of cystatin C in susceptible neurons in Alzheimer's disease.

Authors:  A Deng; M C Irizarry; R M Nitsch; J H Growdon; G W Rebeck
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

5.  Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke.

Authors:  Bo Yang; Jiangtao Zhu; Zhigang Miao; Beiqun Zhou; Wei Ge; Heqing Zhao; Xingshun Xu
Journal:  Neurotox Res       Date:  2015-02-20       Impact factor: 3.911

Review 6.  Choroid plexus recovery after transient forebrain ischemia: role of growth factors and other repair mechanisms.

Authors:  C E Johanson; D E Palm; M J Primiano; P N McMillan; P Chan; N W Knuckey; E G Stopa
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 7.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

8.  Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid Beta Peptide.

Authors:  Monika Pawlik; Magdalena Sastre; Miguel Calero; Paul M Mathews; Stephen D Schmidt; Ralph A Nixon; Efrat Levy
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Hydrogen peroxide induces lysosomal protease alterations in PC12 cells.

Authors:  Daniel C Lee; Ceceile W Mason; Carl B Goodman; Maurice S Holder; Otis W Kirksey; Tracy A Womble; Walter B Severs; Donald E Palm
Journal:  Neurochem Res       Date:  2007-04-18       Impact factor: 3.996

10.  The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases.

Authors:  Jan Mares; P Kanovsky; R Herzig; D Stejskal; J Vavrouskova; P Hlustik; H Vranova; S Burval; J Zapletalova; V Pidrman; R Obereigneru; A Suchy; J Vesely; J Podivinsky; K Urbanek
Journal:  Neurol Sci       Date:  2009-01-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.